ATE357934T1 - Pharmazeutische zusammensetzung zur verhinderung der entwicklung und progression von mykotischen hautoberflächenerkrankungen - Google Patents

Pharmazeutische zusammensetzung zur verhinderung der entwicklung und progression von mykotischen hautoberflächenerkrankungen

Info

Publication number
ATE357934T1
ATE357934T1 AT02425423T AT02425423T ATE357934T1 AT E357934 T1 ATE357934 T1 AT E357934T1 AT 02425423 T AT02425423 T AT 02425423T AT 02425423 T AT02425423 T AT 02425423T AT E357934 T1 ATE357934 T1 AT E357934T1
Authority
AT
Austria
Prior art keywords
progression
development
mycotic
preventing
pharmaceutical composition
Prior art date
Application number
AT02425423T
Other languages
English (en)
Inventor
Valle Francesco Della
Valle Maria Federica Della
Maria Cristina Comelli
Original Assignee
Innovet Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovet Italia Srl filed Critical Innovet Italia Srl
Application granted granted Critical
Publication of ATE357934T1 publication Critical patent/ATE357934T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT02425423T 2002-06-26 2002-06-26 Pharmazeutische zusammensetzung zur verhinderung der entwicklung und progression von mykotischen hautoberflächenerkrankungen ATE357934T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02425423A EP1374903B1 (de) 2002-06-26 2002-06-26 Pharmazeutische Zusammensetzung zur Verhinderung der Entwicklung und Progression von mykotischen Hautoberflächenerkrankungen

Publications (1)

Publication Number Publication Date
ATE357934T1 true ATE357934T1 (de) 2007-04-15

Family

ID=29717032

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02425423T ATE357934T1 (de) 2002-06-26 2002-06-26 Pharmazeutische zusammensetzung zur verhinderung der entwicklung und progression von mykotischen hautoberflächenerkrankungen

Country Status (7)

Country Link
EP (1) EP1374903B1 (de)
AT (1) ATE357934T1 (de)
CY (1) CY1107667T1 (de)
DE (1) DE60219148T2 (de)
DK (1) DK1374903T3 (de)
ES (1) ES2284807T3 (de)
PT (1) PT1374903E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2392436T3 (es) 2005-04-19 2012-12-10 Innovet Italia S.R.L. Composiciones farmacéuticas para el tratamiento de ulceraciones crónicas
CA2764331C (en) * 2009-06-03 2018-07-17 Ex-Tek, Llc Anti-infective skin treatment compositions
US20120277296A1 (en) 2009-07-23 2012-11-01 Sophie Lotersztajn Selective CB2 Receptor Agonists for Use in the Prevention or Treatment of Alcoholic Liver Disease
GB0919210D0 (en) * 2009-11-03 2009-12-16 Syntopix Ltd Formulations
FR2966698B1 (fr) * 2010-10-29 2013-04-26 Dermo Cosmetique Animale Lab De Composition dermo-cosmetique anti-microbienne pour animaux
CN102526019B (zh) * 2011-05-10 2014-07-09 上海莱博生物科技有限公司 松萝酸及其衍生物在制备治疗马拉色菌引起皮肤疾病药物中的用途
HUE044801T2 (hu) * 2014-07-08 2019-11-28 Epitech Group S P A Adelmidrol alkalmazása epitheliális mûködési zavarok kezelésében
CN104606095A (zh) * 2015-01-07 2015-05-13 青岛明药堂医疗股份有限公司 一种海洋花露凝胶及其制备方法
ITUB20160024A1 (it) * 2016-02-04 2017-08-04 Apharm Srl Nuove composizioni topiche comprendenti acido usnico e loro uso in terapia.
CN110420182A (zh) * 2019-08-01 2019-11-08 重庆理工大学 一种松萝酸肝靶向脂微球注射液及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271267B (it) * 1994-12-14 1997-05-27 Valle Francesco Della Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
ATE516264T1 (de) * 1999-07-07 2011-07-15 Innovet Italia Srl Kovalente derivate von mono- und dicarbonsäuren- alkanolamiden, die auf den cb2 cannabinoiden rezeptor wirken
WO2001010402A1 (en) * 1999-08-06 2001-02-15 Innovet Italia S.R.L. Use of n,n1-bis(2-hydroxyethyl)nonandiamide as a cosmetic agent

Also Published As

Publication number Publication date
ES2284807T3 (es) 2007-11-16
DE60219148D1 (de) 2007-05-10
EP1374903B1 (de) 2007-03-28
PT1374903E (pt) 2007-06-22
DK1374903T3 (da) 2007-07-30
DE60219148T2 (de) 2007-12-06
EP1374903A1 (de) 2004-01-02
CY1107667T1 (el) 2013-04-18

Similar Documents

Publication Publication Date Title
CY1107667T1 (el) Φαρμακευτικη συνθεση για την προληψη της αναπτυξης και προοδου μυκητιασικων παθησεων επιφανειας δερματος
BRPI0515316A (pt) compostos de imidazoquinolina
MA40571A (fr) Composition comprenant un melange d'extraits vegetaux ou un melange de molecules contenues dans ces vegetaux et utilisation pour agir sur le metabolisme glucidique et/ou lipidique
BRPI0413490A (pt) novos compostos
CY1115825T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους
SE0001899D0 (sv) New compounds
GT200500363A (es) 3-amino-pirazol [3,4b] piridinas con inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento.
AR047529A1 (es) Compuestos de quinolina sustituidos
UY26130A1 (es) Compuestos para tratar la obesidad
DE602005010876D1 (de) Neuartige biaromatische ppar-rezeptoren aktivierende zusammensetzungen und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.
CR10305A (es) "derivados sustituidos de cromanol y su uso.
PL378238A1 (pl) Związki biaromatyczne, które aktywują receptory typu PPAR<$Egamma>, oraz ich zastosowanie w kompozycjach kosmetycznych albo farmaceutycznych
DE60321916D1 (de) Komprimierte harz-moderierte kaugummi
DE602006011127D1 (de) Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür
DE602006009259D1 (de) Pharmazeutische zusammensetzung mit einem organopoirkstoff
CR8265A (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de enfermedades mediadas por cox-2
PA8542601A1 (es) Bifenilcarboxamidas reductoras de lipidos
DE602007010014D1 (de) Nahrungsergänzungsmittel mit einem protein-aktivator
AR035284A1 (es) Formulaciones en combinacion de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilizacion
BRPI0417950A (pt) composições farmacêuticas
WO2004039326A3 (en) Propofol with cysteine
FR2876875B1 (fr) Protection d'ingredients alimentaires bioactifs par encapsulation
WO2006138431A3 (en) Methods and pharmaceutical formulations for increasing bioavailability
WO2004048351A3 (en) Biphenyl compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1374903

Country of ref document: EP